Clinical trial
The Use of Medical-Expulsive Therapy With Alfuzocine xl 10mg x1/d for Distal…
NCT00489112 · HaEmek Medical Center, Israel, Other · Unknown status
Key facts
| NCT number | NCT00489112 |
|---|---|
| Title | The Use of Medical-Expulsive Therapy With Alfuzocine xl 10mg x1/d for Distal Ureterolithiasis.a Randomized Prospective Study |
| Lead sponsor | HaEmek Medical Center, Israel, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Distal Ureterolithiasis |
| Intervention type | Drug |
| Interventions | Alfuzocine XL 10 mg once a day |
| First posted | Jun 21, 2007 |
| Last update posted | Jun 26, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: